215 related articles for article (PubMed ID: 25677619)
1. Transgene-derived overexpression of miR-17-92 in CD8+ T-cells confers enhanced cytotoxic activity.
Kosaka A; Ohkuri T; Ikeura M; Kohanbash G; Okada H
Biochem Biophys Res Commun; 2015 Mar; 458(3):549-554. PubMed ID: 25677619
[TBL] [Abstract][Full Text] [Related]
2. The TGF-β-inducible miR-23a cluster attenuates IFN-γ levels and antigen-specific cytotoxicity in human CD8⁺ T cells.
Chandran PA; Keller A; Weinmann L; Seida AA; Braun M; Andreev K; Fischer B; Horn E; Schwinn S; Junker M; Houben R; Dombrowski Y; Dietl J; Finotto S; Wölfl M; Meister G; Wischhusen J
J Leukoc Biol; 2014 Oct; 96(4):633-45. PubMed ID: 25030422
[TBL] [Abstract][Full Text] [Related]
3. TGF-beta superfamily enhances the antigen-induced IFN-gamma production by effector/memory CD8+ T cells.
Takai S; Tokuda H; Matsushima-Nishiwaki R; Saio M; Takami T; Kozawa O
Int J Mol Med; 2010 Jan; 25(1):105-11. PubMed ID: 19956908
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of microRNA-21 is associated with elevated pro-inflammatory cytokines in dominant-negative TGF-β receptor type II mouse.
Ando Y; Yang GX; Kenny TP; Kawata K; Zhang W; Huang W; Leung PS; Lian ZX; Okazaki K; Ansari AA; He XS; Invernizzi P; Ridgway WM; Lu Q; Gershwin ME
J Autoimmun; 2013 Mar; 41():111-9. PubMed ID: 23395552
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune vitiligo does not require the ongoing priming of naive CD8 T cells for disease progression or associated protection against melanoma.
Byrne KT; Zhang P; Steinberg SM; Turk MJ
J Immunol; 2014 Feb; 192(4):1433-9. PubMed ID: 24403535
[TBL] [Abstract][Full Text] [Related]
6. Krüppel-like factor KLF10 regulates transforming growth factor receptor II expression and TGF-β signaling in CD8+ T lymphocytes.
Papadakis KA; Krempski J; Reiter J; Svingen P; Xiong Y; Sarmento OF; Huseby A; Johnson AJ; Lomberk GA; Urrutia RA; Faubion WA
Am J Physiol Cell Physiol; 2015 Mar; 308(5):C362-71. PubMed ID: 25472963
[TBL] [Abstract][Full Text] [Related]
7. miR-155 augments CD8+ T-cell antitumor activity in lymphoreplete hosts by enhancing responsiveness to homeostatic γc cytokines.
Ji Y; Wrzesinski C; Yu Z; Hu J; Gautam S; Hawk NV; Telford WG; Palmer DC; Franco Z; Sukumar M; Roychoudhuri R; Clever D; Klebanoff CA; Surh CD; Waldmann TA; Restifo NP; Gattinoni L
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):476-81. PubMed ID: 25548153
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-491 regulates the proliferation and apoptosis of CD8(+) T cells.
Yu T; Zuo QF; Gong L; Wang LN; Zou QM; Xiao B
Sci Rep; 2016 Aug; 6():30923. PubMed ID: 27484289
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effect of lymphotactin and interferon gamma-inducible protein-10 transgene expression in T-cell localization and adoptive T-cell therapy of tumors.
Huang H; Xiang J
Int J Cancer; 2004 May; 109(6):817-25. PubMed ID: 15027114
[TBL] [Abstract][Full Text] [Related]
10. Administration of sulfosuccinimidyl-4-[N-maleimidomethyl] cyclohexane-1-carboxylate conjugated GP100(25-33) peptide-coupled spleen cells effectively mounts antigen-specific immune response against mouse melanoma.
Chang X; Xia CQ
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):46-52. PubMed ID: 26545782
[TBL] [Abstract][Full Text] [Related]
11. Differential interferon-γ production by naive and memory-like CD8 T cells.
de Araújo-Souza PS; Hanschke SCH; Nardy AFFR; Sécca C; Oliveira-Vieira B; Silva KL; Soares-Lima SC; Viola JPB
J Leukoc Biol; 2020 Oct; 108(4):1329-1337. PubMed ID: 32421902
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoids do not inhibit antitumor activity of activated CD8+ T cells.
Hinrichs CS; Palmer DC; Rosenberg SA; Restifo NP
J Immunother; 2005; 28(6):517-24. PubMed ID: 16224268
[TBL] [Abstract][Full Text] [Related]
13. Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8+ T cells: eradication of autologous mouse prostate cancer.
Zhang Q; Yang X; Pins M; Javonovic B; Kuzel T; Kim SJ; Parijs LV; Greenberg NM; Liu V; Guo Y; Lee C
Cancer Res; 2005 Mar; 65(5):1761-9. PubMed ID: 15753372
[TBL] [Abstract][Full Text] [Related]
14. Truncated form of TGF-βRII, but not its absence, induces memory CD8+ T cell expansion and lymphoproliferative disorder in mice.
Ishigame H; Mosaheb MM; Sanjabi S; Flavell RA
J Immunol; 2013 Jun; 190(12):6340-50. PubMed ID: 23686479
[TBL] [Abstract][Full Text] [Related]
15. Effector CD8+ T cell IFN-γ production and cytotoxicity are enhanced by mild hyperthermia.
Mace TA; Zhong L; Kokolus KM; Repasky EA
Int J Hyperthermia; 2012; 28(1):9-18. PubMed ID: 22235780
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of TGF-β signaling in genetically engineered tumor antigen-reactive T cells significantly enhances tumor treatment efficacy.
Zhang L; Yu Z; Muranski P; Palmer DC; Restifo NP; Rosenberg SA; Morgan RA
Gene Ther; 2013 May; 20(5):575-80. PubMed ID: 22972494
[TBL] [Abstract][Full Text] [Related]
17. Genetic engineering of murine CD8+ and CD4+ T cells for preclinical adoptive immunotherapy studies.
Kerkar SP; Sanchez-Perez L; Yang S; Borman ZA; Muranski P; Ji Y; Chinnasamy D; Kaiser AD; Hinrichs CS; Klebanoff CA; Scott CD; Gattinoni L; Morgan RA; Rosenberg SA; Restifo NP
J Immunother; 2011 May; 34(4):343-52. PubMed ID: 21499127
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta1 induces preferential rapid expansion and persistence of tumor antigen-specific CD8+ T cells for adoptive immunotherapy.
Liu S; Etto T; Rodríguez-Cruz T; Li Y; Wu C; Fulbright OJ; Hwu P; Radvanyi L; Lizée G
J Immunother; 2010 May; 33(4):371-81. PubMed ID: 20386469
[TBL] [Abstract][Full Text] [Related]
19. SOCS1 prevents potentially skin-reactive cytotoxic T lymphocytes from gaining the ability to cause inflammatory lesions.
Rodriguez GM; D'Urbano D; Bobbala D; Chen XL; Yeganeh M; Ramanathan S; Ilangumaran S
J Invest Dermatol; 2013 Aug; 133(8):2013-22. PubMed ID: 23443260
[TBL] [Abstract][Full Text] [Related]
20. Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor beta II receptor.
Lucas PJ; Kim SJ; Melby SJ; Gress RE
J Exp Med; 2000 Apr; 191(7):1187-96. PubMed ID: 10748236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
